---
schema_version: "secwatch.filing_event.v1"
accession: "0001485003-21-000152"
form_type: "8-K"
ticker: "CARM"
cik: "0001485003"
company_name: "Carisma Therapeutics Inc."
filed_at: "2021-07-21T23:59:59+00:00"
generated_at: "2026-06-30T03:43:24.621604+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Sesen Bio appoints two new directors with regulatory and clinical expertise

## Summary
- Peter K Honig, MD (former Pfizer global regulatory head) and Michael A.S. Jewett, MD (urologic oncologist and Order of Canada) elected to Board.
- Board size increased from 5 to 7 members; both appointed effective July 20, 2021.
- Each new director received initial option to purchase 185,000 shares at $3.86 per share.
- Company reiterates on track for FDA decision on Vicineum BLA by PDUFA date August 18, 2021.

## SEC filing metadata
- accession: 0001485003-21-000152
- form_type: 8-K
- ticker: CARM
- cik: 0001485003
- company_name: Carisma Therapeutics Inc.
- filed_at: 2021-07-21T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1485003/000148500321000152/0001485003-21-000152-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1485003/000148500321000152/sesn-20210720.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001485003-21-000152
- JSON: https://secwatch.observer/filing/0001485003-21-000152.json
- Plain text: https://secwatch.observer/filing/0001485003-21-000152.txt

## Key facts
- Executive change
  Michael A.S. Jewett, M.D. was elected as Director at Carisma Therapeutics Inc..
  - Action: elected
  - Role: Director
  source text: elected Peter K Honig, M.D. and Michael A.S. Jewett, M.D. to the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1485003/000148500321000152/0001485003-21-000152-index.htm
- Executive change
  Peter K Honig, M.D. was elected as Director at Carisma Therapeutics Inc..
  - Action: elected
  - Role: Director
  source text: elected Peter K Honig, M.D. and Michael A.S. Jewett, M.D. to the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1485003/000148500321000152/0001485003-21-000152-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.